These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 25934814)
21. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583 [TBL] [Abstract][Full Text] [Related]
22. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report. Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597 [TBL] [Abstract][Full Text] [Related]
23. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure. Saint-Marcoux F; Woillard JB; Jurado C; Marquet P Ther Drug Monit; 2013 Jun; 35(3):322-7. PubMed ID: 23666572 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344 [TBL] [Abstract][Full Text] [Related]
31. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus. Tsuchiya T; Ishida H; Tanabe T; Shimizu T; Honda K; Omoto K; Tanabe K Transplantation; 2013 Jul; 96(2):198-204. PubMed ID: 23792649 [TBL] [Abstract][Full Text] [Related]
32. Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. Naesens M; Salvatierra O; Li L; Kambham N; Concepcion W; Sarwal M Transplantation; 2008 Apr; 85(8):1139-45. PubMed ID: 18431234 [TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus. Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655 [TBL] [Abstract][Full Text] [Related]
34. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Staatz CE; Taylor PJ; Lynch SV; Tett SE Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793 [TBL] [Abstract][Full Text] [Related]
35. Tacrolimus in pediatric renal transplantation: a review. Shapiro R Pediatr Transplant; 1998 Nov; 2(4):270-6. PubMed ID: 10084728 [TBL] [Abstract][Full Text] [Related]
36. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831 [TBL] [Abstract][Full Text] [Related]
37. Ranolazine-tacrolimus interaction. Pierce DA; Reeves-Daniel AM Ann Pharmacother; 2010 Nov; 44(11):1844-9. PubMed ID: 20876828 [TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation. Musuamba FT; Guy-Viterbo V; Reding R; Verbeeck RK; Wallemacq P Ther Drug Monit; 2014 Feb; 36(1):54-61. PubMed ID: 24081207 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic monitoring of tacrolimus. Trull AK Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():167-80. PubMed ID: 9547889 [No Abstract] [Full Text] [Related]
40. Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade. Peynaud D; Charpiat B; Vial T; Gallavardin M; Ducerf C Eur J Clin Pharmacol; 2007 Jul; 63(7):721-2. PubMed ID: 17530235 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]